Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Last Updated: 2026

Singular Genomics Systems

Rank#9562

Market Cap50.77M

CountryUnited States

Summary

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

History

Singular Genomics was founded in 2010 by its two current principals, Drs. Steven Quake and Dino Di Carlo. Both hold a PhD in electrical engineering from Stanford University and were drawn by their shared interest in studying complex biological systems. Since its founding, Singular Genomics has been committed to developing new tools and technologies to advance the field of life science research.

Mission

To empower life science research using innovative technologies and ideas by enabling our global customers to make more informed decisions, more quickly.

Vision

To become the world’s leading provider of innovative life science tools that enable researchers to make more informed decisions, more quickly.

References

https://in.investing.com/equities/singular-genomics-systems

https://finance.yahoo.com/quote/OMIC/profile?p=OMIC

https://www.crunchbase.com/organization/singular-genomics#:~:text=Singular%20Genomics'%20core%20product%20tenets,as%20the%20G4%20Integrated%20Solution.

https://companiesmarketcap.com/

https://singulargenomics.com

Leadership team

Mr. Andrew Spaventa (Founder, CEO, Pres & Chairperson of the Board)

Dr. David L. Barker Ph.D. (Founder, Member of Scientific Advisory Board & Independent Director)

Ms. Daralyn Durie (Gen. Counsel)

Products / Services

Biotechnology, Health Care, Medical

Number of Employees

100 - 500

Address

La Jolla, California, United States

Established

2016-01-01

Company Registration

SEC CIK number: 0001850906

Traded as

OMIC

Website

https://singulargenomics.com

Social Media

Last Updated: 2026

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More

Last Updated: 2026

Singular Genomics Systems

Rank#9562

Market Cap50.77M

CountryUnited States

Summary

History

Mission

To empower life science research using innovative technologies and ideas by enabling our global customers to make more informed decisions, more quickly.

Vision

To become the world’s leading provider of innovative life science tools that enable researchers to make more informed decisions, more quickly.

References

https://in.investing.com/equities/singular-genomics-systems

https://finance.yahoo.com/quote/OMIC/profile?p=OMIC

https://www.crunchbase.com/organization/singular-genomics#:~:text=Singular%20Genomics'%20core%20product%20tenets,as%20the%20G4%20Integrated%20Solution.

https://companiesmarketcap.com/

https://singulargenomics.com

Leadership team

Mr. Andrew Spaventa (Founder, CEO, Pres & Chairperson of the Board)

Dr. David L. Barker Ph.D. (Founder, Member of Scientific Advisory Board & Independent Director)

Ms. Daralyn Durie (Gen. Counsel)